medline.ch Neurologie Multiple Sklerose

	Prescribing Resistance Training in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Phys Med Rehabil Yang FA, Chen HC, Wu PJ, Chi TW, Chu YC, Huang CC. PMID: 42155970 [PubMed - as supplied by publisher]
	Distribution of IL-33 genetic variants and circulating IL-33 levels in patients with multiple sclerosis: associations with clinical parameters in a Lithuanian population study. Mult Scler Relat Disord Kaikaryte K, Vilkeviciute-Petraite A, Balnyte R, Uloziene I, Liutkeviciene R. PMID: 42155380 [PubMed - as supplied by publisher]
	Complementary therapies for multiple sclerosis: Scoping review with evidence gap map. Mult Scler Relat Disord Lopez-Alcalde J, Yan Y, Canella C, Barth J, Steinemann N, von Wyl V, Baum C, Bolt S, Haegele-Link S, Grob GR, Tietjen AK, Álvarez-Díaz N, Witt CM. PMID: 42155379 [PubMed - as supplied by publisher]
	Beyond chronological age: biological aging and its relevance for motor and cognitive function in multiple sclerosis. Neurodegener Dis Manag Monaghan PG, Johnson KA, Bove R, Fling BW, Fritz NE. PMID: 42153472 [PubMed - as supplied by publisher]
	Transcranial magnetic stimulation in multiple sclerosis: Targeting symptoms through neuroplasticity. Mult Scler Nazzi C, Turrini S, Pezzetta R, Scarpazza C, Avenanti A, Battaglia S. PMID: 42153440 [PubMed - as supplied by publisher]
	Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis. Arch Phys Med Rehabil Mistretta EG, Ehde DM, Turner AP, Alschuler KN, Fritz NE, Kratz AL. PMID: 42150724 [PubMed - as supplied by publisher]
	Translingual neural stimulation to improve gait and balance in multiple sclerosis: A randomized controlled trial. Arch Phys Med Rehabil Donkers SJ, Lohse KR, Melam GR, Buragadda S, Levin MC, Clift F, Stefanelli M, Ploughman M. PMID: 42150723 [PubMed - as supplied by publisher]
	Real-world experience with rituximab for multiple sclerosis treatment in a Brazilian tertiary center. Arq Neuropsiquiatr Simon-Nogueira AB, Holanda AC, Rosalem RA, Santillan TIV, Silva GD, Apostolos-Pereira SL, Adoni T, Callegaro D, Spricigo MG, Oliveira MB. PMID: 42150598 [PubMed - indexed for MEDLINE]
	Correction: Ozone pollution as a possible trigger for multiple sclerosis in young people: the PEDIGREE study. J Neurol Bergamaschi R, Ferraro OE, Pisoni E, Fronza M, Bova S, Annovazzi P, Simone M, Gallo A, Suppiej A, Lanzillo R, Rasia S, Berardinelli A, Torri Clerici V, Moiola L, Viri M, Sotgiu S, Malucchi S, Protti A, Canavese C, Lus G, Grimaldi LM, Conti M, Borriello G, De Luca G, Tomassini V, Priori A, Tosi M, Pomella N, Corona A, Zollo A, Amato MP, Cocco E, Trojano M, Martinelli-Boneschi F, Tavazzi E, Montomoli C, D'Alfonso S, Ghezzi A, Pilotto S, Pugliatti M, PEDIGREE Study Group. PMID: 42149220 [PubMed - in process]
	Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights. Front Immunol Ganelin-Cohen E, Wexler Y, Kraus S, Rozenberg A. PMID: 42148068 [PubMed - indexed for MEDLINE]
	Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study. Front Neurol Khedr EM, Karim AA, Ezzeldin MY, Abdelwarith A, Ahmed GK, Haridy NA. PMID: 42147835 [PubMed]
	Fluid biomarkers in multiple sclerosis: Indicators of disease activity, progression, and treatment response. Mult Scler Relat Disord Tahmasbi Arashlow F, Fekri M, Salarvandian S, Darfarin K, Esmaeilpour K, Ebrahimi R. PMID: 42143974 [PubMed - as supplied by publisher]
	Efficacy of SativexÂ® on Pain, Spasticity, and Disability in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis. Pharmacol Res Nucera S, Ilari S, Caminiti R, Mazza V, Proietti S, Pulone S, Moulton C, Maiuolo J, Passacatini LC, Mollace V, Tasciotti E, Muscoli C. PMID: 42142680 [PubMed - as supplied by publisher]
	A multilevel linguistic analysis reveals linguistic impairments in persons with multiple sclerosis. J Commun Disord Gobbo M, Gabbatore I, Piovani G, Bosco FM, Marini A, Tacchino A. PMID: 42142516 [PubMed - as supplied by publisher]
	IGFBP7 in multiple sclerosis: A marker of compartmentalized inflammation with limited diagnostic specificity. Mult Scler Relat Disord Sokmen O. PMID: 42142450 [PubMed - as supplied by publisher]
	No evidence for a causal link between plasma lipids and multiple sclerosis susceptibility and severity: A Mendelian randomisation study. J Neurol Sci Nagrodzki J, Proitsi P, Tan M, Dobson R, Jacobs BM. PMID: 42142449 [PubMed - as supplied by publisher]
	Bilateral fuchs uveitis syndrome and its association with multiple sclerosis. Int Ophthalmol Kasapoglu GG, Altan C, Ozkocak BY, Atik BK, Basarir B. PMID: 42142135 [PubMed - indexed for MEDLINE]
	Comparative Effectiveness and Safety of Rituximab Versus Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Finnish Population-Based Matched Cohort Study. Eur J Neurol Savolainen M, Soilu-Hänninen M, Nurmi H, Viitala M, Tienari P, Atula S, Laakso SM. PMID: 42141836 [PubMed - indexed for MEDLINE]
	Efficacy of transcranial direct current stimulation on motor and cognitive functions in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol Ahmed GU, Abbas H, Komal F, Muskan F, Tharwani A, Khiani RK, Ramani S, Raza AA, Shaikh JG, Sanaullah O, Samadi A. PMID: 42141416 [PubMed - as supplied by publisher]
	Comment on "A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis". J Neurol Sci Sinha AP. PMID: 42139985 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 44025

Seite 1 von 2202

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung